Notice of Additional Investment in Metagen Therapeutics
Keio Innovation Initiative (KII) has invested in Metagen Therapeutics, a microbiome drug discovery company, through a fund managed by KII. Metagen Therapeutics will raise a total of 140 million yen through this capital increase to accelerate the expansion of its business.
For more details, please see the press release.
https://prtimes.jp/main/html/rd/p/000000037.000018580.html